Beta-Blockers in Takotsubo Syndrome Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT06509074
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT06509074
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06509074. Randomized; single masking; primary purpose treatment. Start 2024-08 (anticipated); primary completion 2025-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Beta-Blockers in Takotsubo Syndrome Study
- Acronym
- β-Tako
- Condition
- Takotsubo Cardiomyopathy
- Condition
- Beta-blockers
- Condition
- Echocardiography
- Condition
- Left Ventricular Function
- Intervention (Drug)
- Beta blocker
- Lead sponsor
- Spanish Society of Cardiology
- Collaborator
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Record details
- Record id
cardio:ct-nct06509074- Content hash
1b0a7bda24916f30679841ab1c30c501280aa1c796b4a192cae292884adc93a3